Managing a BLVR Program With SeleCT™ Screening: A One-Year Review

Insights from the University of Chicago’s BLVR program success with Olympus® SeleCT™ Screening powered by 4DMedical.

Access Review

Transforming BLVR Patient Selection

Bronchoscopic lung volume reduction (BLVR) is a recommended treatment strategy for patients with severe emphysema, but the candidate selection process is cumbersome and time-consuming. Many patients are found ineligible at the last step of the manual workup, resulting in disappointment for the patients as well as avoid unnecessary workups.

For the University of Chicago, that changed when they adopted Olympus SeleCT Screening, the first AI-driven solution for streamlined BLVR patient selection. By leveraging AI algorithms to automatically analyze CT scans performed within the health system, SeleCT Screening helped identify eligible patients who would have otherwise slipped through the cracks — all without creating extra work for their team.

 

SeleCT Screening Results After One Year

blue check

6,970 Chest CT Scans Screened

blue check

657 Scans That Met SeleCTion Criteria

blue check

88 Potential Patients Qualified

See the University’s Results

Access the case study to see how the University of Chicago overcame their struggles with BLVR patient selection and achieved success with Olympus® SeleCT™ Screening.

How Olympus SeleCT™ Screening Works

Watch Now

quote icon
Why would you not want something that is going to make everything more efficient when you are going to implement a valve program? It is truly the easy button.”

 

D. Kyle Hogarth, MD, FCCP
Pulmonologist | Professor of Medicine

Dr. Hogarth is a paid consultant of the Olympus Corporation, its subsidiaries and/or its affiliates.The statements made by Dr. Hogarth are based on Dr. Hogarth’s experiences, thoughts and opinions and do not necessarily represent the views or opinions of Olympus. As with any product, results may vary and the techniques, instruments and settings can vary from facility to facility.

 
 

Enhance Your BLVR Program with SeleCT Screening

SeleCT Screening is designed to uncover enriched patient populations with no extra work for your team. See how it can streamline your BLVR program.

Potential complications which may be associated with bronchoscopy and/or the Spiration™ Valve System may include, but are not limited to, pneumothorax, worsening of COPD symptoms, pneumonia, dyspnea and in rare cases, death. Prior to using the Spiration Valve System, please review the full list of risks and complications at https://spirationvalve.com/potential-risks-complications for additional information on indications, contraindications, warnings, precautions and potential complications.

Contact Us